...
首页> 外文期刊>Experimental and therapeutic medicine >Daidzein ameliorates spinal cord ischemia/reperfusion injury-induced neurological function deficits in Sprague-Dawley rats through PI3K/Akt signaling pathway
【24h】

Daidzein ameliorates spinal cord ischemia/reperfusion injury-induced neurological function deficits in Sprague-Dawley rats through PI3K/Akt signaling pathway

机译:Daidzein改善脊髓缺血/再灌注损伤诱导的Spri3K / AKT信号通路在Sprague-Dawley大鼠中的神经功能缺陷

获取原文
获取原文并翻译 | 示例
           

摘要

Daidzein (DZ) has a broad spectrum of biological activities, including antioxidant, anti-inflammatory and anticancer as well as cardio- and hepatoprotective properties. The present study was designed to elucidate the in-depth mechanism underlying the neuroprotective efficacy of DZ against spinal cord ischemic/reperfusion injury (SCII) in a rat model by comparison with the standard neuroprotective agent methylprednisolone (MP). A total of 48 rats were divided into four groups of twelve rats in each (n= 12). In sham-operated group (Control) group, rats received only saline (Fogarty catheter was inserted without balloon inflation), whereas rats in the SCII induction group (SCII) were subjected to SCII insult by insertion of a Fogarty balloon catheter, which was inflated in the descending thoracic aorta to cause an occlusion. A proportion of rats was treated with DZ (20 mg/kg; DZ+SCII group) or MP (50 mg/kg; MP+SCII group) for seven days prior to and after SCII. The locomotor function (neurological activity) and antioxidant levels (superoxide dismutase and catalase) levels were significantly improved upon treatment with DZ and MP in comparison with those in the SCII group. A concomitant decline in edema, inflammatory markers (myeloperoxidase, tumor necrosis factor-alpha and nuclear factor kappa B p65), the apoptotic marker caspase-3 and the number of cells with terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling was also observed in the DZ and MP groups. The protein levels of phosphoinositide-3 kinase (PI3K), the phosphorylated Akt/Akt ratio and B-cell lymphoma 2 (Bcl-2) were substantially downregulated, while Bcl-2-associated X protein levels were upregulated SCII insult group, which was inhibited by treatment with DZ. To conclude, pre-treatment with DZ significantly improved the neurological function by upregulating PI3K/Akt signaling and thereby considerably attenuating the inflammatory response and apoptosis, thus maintaining the neuronal count in an SCII-induced rat model.
机译:Daidzein(DZ)具有广泛的生物活性,包括抗氧化剂,抗炎和抗癌以及心血管和肝保护性能。本研究旨在通过与标准神经保护剂甲基己酮(MP)进行比较,阐明DZ对DZ对脊髓缺血性/再灌注损伤(SCII)的神经保护效果的深度机制。总共48只大鼠分为四组(n = 12)。在假手术组(对照)组中,大鼠只接受盐水(无球囊通胀插入的盐水),而SCII诱导组(SCII)的大鼠通过插入膨胀的球囊导管进行SCII侮辱,膨胀在下降的胸主动脉中引起闭塞。在SCII之前和之后用DZ(20mg / kg; DZ + SCII组)或MP(50mg / kg; MP + SCII组)处理比例的大鼠。与SCII组中的那些相比,在用DZ和MM处理时,在用DZ和MM处理后显着改善了运动功能(神经学活动)和抗氧化剂水平(超氧化物歧化酶和过氧化氢酶)水平。还观察到水肿,炎症标志物(炎氧化酶,肿瘤坏死因子-α和核因子Kappa P65),凋亡标记胱天冬酶-3和末端脱氧核苷酸转移酶介导的DUTP内乳蛋白末端标记的凋亡标记酶-3和细胞数量DZ和MP组。基本上下调磷酸阳性-3激酶(PI3K),磷酸化的AKT / Akt比和B细胞淋巴瘤2(BCL-2)的蛋白质水平,而BCL-2相关的X蛋白水平是上调的SCII侮辱组,即用DZ治疗抑制。为了得出结论,通过上调PI3K / AKT信号传导,DZ预处理显着改善了神经功能功能,从而显着衰减炎症反应和凋亡,从而保持了SCII诱导的大鼠模型中的神经元计数。

著录项

  • 来源
  • 作者单位

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

    China Three Gorges Univ Peoples Hosp Yichang 1 Dept Orthoped 2 Jiefang Rd Yichang 443000 Hubei;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

    spinal cord ischemia reperfusion; daidzein; methylprednisolone; edema; inflammatory markers; apoptosis;

    机译:脊髓缺血再灌注;Daidzein;甲基己二龙;水肿;炎症标志物;细胞凋亡;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号